Combination studies revealed that downregulating the antiapoptotic genes, especially the Bcl2 family members, sensitizes the cancer cells to apoptosis and promotes tumor elimination (Kojima et al., 2006; Kracikova et al., 2013). The gene discussed is BCL2; the disease is neoplasm.